Didactics-Adjuvant Therapy for High Risk Endometrial Cancer

Video Transcription

Video Summary

In this video, the speaker discusses the incidence and treatment of endometrial cancer. The speaker mentions that endometrial cancer is increasing in developing countries and is the most common gynecological cancer in the developed world. The incidence in the United States is 3.1% and 8-10% of patients with postmenopausal bleeding are diagnosed with cancer. The speaker also discusses the staging of endometrial cancer and addresses some areas where the staging guidelines do not provide clear classification. They discuss different risk groups and the factors that determine the need for adjuvant therapy after surgery. The speaker mentions that radiation therapy and chemotherapy are commonly used as adjuvant treatment, with taxol and carboplatin being the preferred chemotherapy regimen due to its effectiveness and lower toxicity. The speaker also mentions the results of different studies that compare chemotherapy and radiation therapy and the potential benefits of combining the two treatments. The video concludes by highlighting the need for further research to determine the optimal treatment approach for different subtypes of endometrial cancer.

Asset Subtitle

Tri Dinh
July 2020

Keywords

endometrial cancer

incidence

treatment

staging

adjuvant therapy

chemotherapy